ConductScience.org, home

Trial · NCT00377403

Treatment of Acute Sinusitis

NCT00377403, Phase 4, Completed, Washington University School of Medicine; results first posted 2011-06-29

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Treatment of Acute Sinusitis. Trials, record NCT00377403. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00377403

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Treatment of Acute Sinusitis
NCT number
NCT00377403
Status
Completed
Phases
Phase 4
Enrollment
172 participants, actual
Lead sponsor
Washington University School of Medicine
Conditions
Acute Respiratory Infections, Acute Rhinosinusitis
Interventions
Acetaminophen, Amoxicillin, Dextromethorphan hydrobromide with guaifenesin, Guaifenesin, Pseudoephedrine Sustained Action, Saline spray (0.65%)
First posted
2006-09-18
Last updated
2012-12-28
Results first posted
2011-06-29

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySNOT-16 Score (Sino-Nasal Outcomes Test) at Day 34 days
The Sino-Nasal Outcomes Test (SNOT-16) assesses disease-specific quality of life for acute and chronic rhinosinusitis. This brief instrument assesses 16 sinus-related symptoms and was administered by phone. The respondent reported how much they were bothered by each item considering both its severity and frequency. Response options include no problem (0), mild or slight problem (1), moderate problem (2), severe problem (3). The SNOT-16 score is the mean score from all 16 items and ranges from 0 (minimal impact) to 3 (significant impact).

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYSNOT-16 Score (Sino-Nasal Outcomes Test) at Day 34 daysWe analysed all participants for whom we had data at Day 3. We were unable to complete the telephone interview with 11 subjects.Units on a scaleMEAN

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
SNOT-16 Score (Sino-Nasal Outcomes Test) at Day 3Intervention Arm1.12Standard Deviation 0.54Units on a scale
SNOT-16 Score (Sino-Nasal Outcomes Test) at Day 3Symptomatic Treatments Only1.14Standard Deviation 0.55Units on a scale

Participant flow14

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDIntervention Arm85
Overall StudySTARTEDSymptomatic Treatments Only81
Overall StudyDay -3 AssessmentIntervention Arm81
Overall StudyDay -3 AssessmentSymptomatic Treatments Only74
Overall StudyDay 7 AssessmentIntervention Arm80
Overall StudyDay 7 AssessmentSymptomatic Treatments Only75
Overall StudyDay 10 AssessmentIntervention Arm81
Overall StudyDay 10 AssessmentSymptomatic Treatments Only71
Overall StudyDay 28 AssessmentIntervention Arm82
Overall StudyDay 28 AssessmentSymptomatic Treatments Only77

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherOther non-serious adverse eventsGeneral disordersIntervention Arm398539
otherOther non-serious adverse eventsGeneral disordersSymptomatic Treatments Only368136

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityIntervention Arm
Total, all-cause mortalitySymptomatic Treatments Only
Total, other adverse eventsIntervention Arm3985
Total, other adverse eventsSymptomatic Treatments Only3681
Total, serious adverse eventsIntervention Arm085
Total, serious adverse eventsSymptomatic Treatments Only081

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
21844413DERIVEDPubMed
22337680DERIVEDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
U01AI064655RCT to evaluate guidelines for acute rhinosinusitisGARBUTT, JANE MWASHINGTON UNIVERSITYNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES2006 to 2008

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Intervention Arm vs Symptomatic Treatments Only: serious adverse events

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00377403

GET https://conductscience.org/api/trials/v1/NCT00377403/registered